Case reports of juvenile GM1 gangliosidosisis type II caused by mutation in GLB1 gene

被引:14
|
作者
Karimzadeh, Parvaneh [1 ]
Naderi, Samaneh [2 ]
Modarresi, Farzaneh [3 ]
Dastsooz, Hassan [4 ]
Nemati, Hamid [7 ]
Farokhashtiani, Tayebeh [1 ]
Shamsian, Bibi Shahin [5 ]
Inaloo, Soroor [6 ]
Faghihi, Mohammad Ali [3 ]
机构
[1] Shahid Beheshti Univ Med Sci SBMU, Pediat Neurol Dept, Pediat Neurol Res Ctr, Tehran, Iran
[2] Shiraz Univ Med Sci, Sch Paramed Sci, Diagnost Lab Sci & Technol Res Ctr, Shiraz, Iran
[3] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Ctr Therapeut Innovat, Miami, FL 33136 USA
[4] Shiraz Univ Med Sci, Comprehens Med Genet Ctr, Shiraz, Iran
[5] Shahid Beheshti Univ Med Sci, Pediat Congenital Hematol Disorders Res Ctr, Tehran, Iran
[6] Shiraz Univ Med Sci, Neonatal Res Ctr, Shiraz, Iran
[7] Shiraz Univ Med Sci, Shiraz Neurosci Res Ctr, Shiraz, Iran
来源
BMC MEDICAL GENETICS | 2017年 / 18卷
关键词
GM1; gangliosidosis; GLB1; Case report; BETA-GALACTOSIDASE DEFICIENCY; GM1-GANGLIOSIDOSIS; PATHOGENESIS; FAMILIES; DISEASE;
D O I
10.1186/s12881-017-0417-4
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Type II or juvenile GM1-gangliosidosis is an autosomal recessive lysosomal storage disorder, which is clinically distinct from infantile form of the disease by the lack of characteristic cherry-red spot and hepatosplenomegaly. The disease is characterized by slowly progressive neurodegeneration and mild skeletal changes. Due to the later age of onset and uncharacteristic presentation, diagnosis is frequently puzzled with other ataxic and purely neurological disorders. Up to now, 3-4 types of GM1-gangliosidosis have been reported and among them type I is the most common phenotype with the age of onset around 6 months. Various forms of GM1-gangliosidosis are caused by GLB1 gene mutations but severity of the disease and age of onset are directly related to the position and the nature of deleterious mutations. However, due to its unique genetic cause and overlapping clinical features, some researchers believe that GM1 gangliosidosis represents an overlapped disease spectrum instead of four distinct types. Case presentation: Here, we report a less frequent type of autosomal recessive GM1 gangliosidosis with perplexing clinical presentation in three families in the southwest part of Iran, who are unrelated but all from " Lurs" ethnic background. To identify disease-causing mutations, Whole Exome Sequencing (WES) utilizing next generation sequencing was performed. Four patients from three families were investigated with the age of onset around 3 years old. Clinical presentations were ataxia, gate disturbances and dystonia leading to wheelchair-dependent disability, regression of intellectual abilities, and general developmental regression. They all were born in consanguineous families with no previous documented similar disease in their parents. A homozygote missense mutation in GLB1 gene (c. 601 G > A, p. R201C) was found in all patients. Using Sanger sequencing this identified mutation was confirmed in the proband, their parents, grandparents, and extended family members, confirming its autosomal recessive pattern of inheritance. Conclusions: Our study identified a rare pathogenic missense mutation in GLB1 gene in patients with complex neurodevelopmental findings, which can extend the list of differential diagnoses for childhood ataxia in Iranian patients.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] New GLB1 mutation in siblings with Morquio type B disease presenting with mental regression
    Mayer, Fabiana Quoos
    Pereira, Femanda dos Santos
    Fensom, Anthony H.
    Slade, Christina
    Matte, Ursula
    Giugliani, Roberto
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (03) : 148 - 148
  • [32] Phase 1/2 trial of AXO-AAV-GM1 (AAV9-GLB1) gene therapy for infantile- and juvenile-onset GM1 gangliosidosis
    Tifft, Cynthia
    D'Souza, Precilla
    Johnston, Jean M.
    Acosta, Maria T.
    Nicoli, Elena-Raluca
    Rothermel, Caroline
    Thurm, Audrey
    Karunakara, Ajith
    Thorp, Benjamin
    Ross, Peter
    Jameson, John
    Sheehan, Michael
    Vaughn, Toby
    Valencia, Donna
    De Boever, Erika
    Corcoran, Gavin
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S119 - S119
  • [33] Intravenous delivery of AAV9-GLB1 gene therapy for GM1 gangliosidosis: An interim analysis
    D'Souza, Precilla
    Johnston, Jean M.
    Thurm, Audrey
    Farmer, Cristan
    Gross, Amanda L.
    Acosta, Maria T.
    Tifft, Cynthia
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [34] A CASE OF GM1 GANGLIOSIDOSIS TYPE-I
    CABRAL, A
    PORTELA, R
    TASSO, T
    EUSEBIO, F
    MOREIRA, A
    DOSSANTOS, HM
    SOARES, J
    MOURANUNES, JF
    OPHTHALMIC PAEDIATRICS AND GENETICS, 1989, 10 (01): : 63 - 67
  • [35] GLB1基因变异致GM1神经节苷脂贮积症Ⅱ型1例报告并文献复习
    李甜馨
    陆相朋
    彭琰琰
    卢婷婷
    廉文君
    冯斌
    都修波
    马丙祥
    郑宏
    临床儿科杂志, 2021, 39 (11) : 813 - 817
  • [36] ATYPICAL GM1 GANGLIOSIDE ACCUMULATION IN A CASE OF JUVENILE AMAUROTIC IDIOCY
    OGINO, T
    OSUKA, T
    YOKOI, S
    CLINICA CHIMICA ACTA, 1977, 78 (01) : 9 - 16
  • [37] CHARACTERIZATION OF GLB1 cDNA FROM NORMAL AND GM1-GANGLIOSIDOSIS AFFECTED OVINE FIBROBLASTS TO CONFIRM A POSSIBLE DISEASE-CAUSING MUTATION
    Dieter, Brady R.
    Bailey, David O.
    Isikbay, Masis
    Ahern-Rindell, Amelia J.
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (03) : 269 - 269
  • [38] GENERALIZED GANGLIOSIDOSIS TYPE-II (JUVENILE GM1 GANGLIOSIDOSIS) - PATHOLOGICAL, HISTOCHEMICAL AND ULTRASTRUCTURAL STUDY
    GILBERT, EF
    VARAKIS, J
    OPITZ, JM
    ZURHEIN, GM
    WARE, R
    VISESKUL, C
    KAVEGGIA, EG
    HARTMANN, HA
    ZEITSCHRIFT FUR KINDERHEILKUNDE, 1975, 120 (03): : 151 - 180
  • [39] RETINAL PATHOLOGY IN GM1 GANGLIOSIDOSIS, TYPE-II
    GOEBEL, HH
    FIX, JD
    ZEMAN, W
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1973, 75 (03) : 434 - 441
  • [40] Creation of an in vitro model of GM1 gangliosidosis by CRISPR/Cas9 knocking-out the GLB1 gene in SH-SY5Y human neuronal cell line
    Hosseini, Kamran
    Fallahi, Jafar
    Aligholi, Hadi
    Heidari, Zahra
    Nadimi, Elham
    Safari, Fatemeh
    Sisakht, Mohsen
    Atapour, Amir
    Khajeh, Sahar
    Tabei, Seyed Mohammad Bagher
    Razban, Vahid
    CELL BIOCHEMISTRY AND FUNCTION, 2024, 42 (06)